Health Care Leader Cigna Proudly Donates $1 Million to Help Build Martin Luther King, Jr. National Memorial in Washington, D.C.
PHILADELPHIA and BLOOMFIELD, Conn., Jan. 14, 2007 /PRNewswire/ -- Cigna, a leader in health and related benefits, has donated $1 million to help build a lasting memorial to Dr. Martin Luther King, Jr. in Washington, D.C. The announcement will be made tomorrow on Martin Luther King Day by Harry E. Johnson, Sr., president of the Washington, D.C. Martin Luther King Jr. National Memorial Project Foundation, Inc.
"Sponsorship of the Martin Luther King, Jr. Memorial is a fitting tribute to a passionate civil rights advocate who was larger than life," said Cigna Chairman and CEO H. Edward Hanway. "Martin Luther King inspired and challenged us to overcome adversity and make a positive difference in our community and our country. Through this memorial, Martin Luther King, Jr.'s message will ring true for generations to come," Hanway said.
As the only health care company to date to sponsor the memorial at the million-dollar level, Cigna encouraged its colleagues in business and industry to follow its lead.
The permanent memorial on the National Mall will be positioned between the Jefferson and Lincoln Memorials and will symbolize for all Americans the unbroken link between the Jeffersonian ideals on which America was founded, the protection and salvation of those ideals by President Lincoln, and the struggle by Dr. King to fulfill those ideals.
About the Washington, DC Martin Luther King, Jr. National Memorial Project Foundation, Inc.
A memorial honoring Dr. Martin Luther King, Jr. will be built on the National Mall in Washington, D.C. The Memorial will be situated adjacent to the F.D.R. Memorial and in a direct line between the Lincoln and Jefferson Memorials. Congress passed Joint Resolutions in 1996 authorizing Alpha Phi Alpha Fraternity, Inc. to establish a memorial honoring Dr. King to be built in Washington, D.C. The Ceremonial Groundbreaking took place on November 13, 2006 and the Memorial is scheduled to be completed in 2008. Website: http://www.buildthedream.org/.
For more information about the Washington, D.C. Martin Luther King, Jr. National Memorial Project, visit http://www.buildthedream.org/.
As a Business of Caring, Cigna (NYSE: CI) provides employers with benefits, expertise and services that improve the health, well-being and productivity of their employees. With approximately 47 million covered lives in the United States and around the world, Cigna's operating subsidiaries offer a full portfolio of medical, dental, behavioral health, pharmacy and vision care benefits and group life, accident and disability insurance.
Cigna expresses its commitment to improving the health of individuals and families and enhancing the well-being of local communities through a charitable giving and civic involvement program. The program stresses support for non-profit organizations working in key areas of health-related concerns and encouragement of employee volunteer activities. To learn more about Cigna's giving go to http://www.cigna.com/about_us/community/index.html.
CONTACT: Rica Rodman Orszag, of the Washington, D.C. Martin Luther King,
Jr. National Memorial Project Foundation, Inc., +1-202-253-8974,
firstname.lastname@example.org; or Gloria Barone of Cigna, +1-215-761-4758,
Company News On-Call: http://www.prnewswire.com/comp/141893.html
Other articles in News Releases:
- Cigna Waives Customer Cost-Sharing For COVID-19 Treatment And Deploys Clinical Teams To Increase Virtual Care Capacity
- Cigna Makes It Easier For Hospitals To Focus On COVID-19 By Helping Accelerate Patient Transfers
- Cigna Expands Benefits To Support And Protect Its Workforce In Response To COVID-19
- Cigna Corporation Announces Pricing Terms of Tender Offers for up to $1.45 billion in Aggregate Principal Amount of Outstanding Notes
- Cigna Corporation Announces Early Results of Tender Offers for up to $1.45 billion in Aggregate Principal Amount of Outstanding Notes
- Cigna Takes Additional Actions To Protect Customers And Communities Against COVID-19